Showing results (241-250 of 584) with videos related to

Sort By:
Pageof 59
JTO Clinical and Research Reports|December 6, 2022
Unexpected Cardiotoxicity in Patients With HER2-Mutant NSCLC Treated With Trastuzumab Deruxtecan: A Case ReportMariona Riudavets, Arshid Azarine, Sondes Smaali, et al.
Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Oncotarget|March 14, 2019
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.
Oncotarget|January 17, 2019
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in CancerArthur Géraud, David Combarel, Christian Funck-Brentano, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2019
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessmentSami Antoun, Hugues Morel, Pierre-Jean Souquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Targeted Oncology|August 15, 2014
Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLCCecile Bosc, Gilbert R Ferretti, Jacques Cadranel, et al.
Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.
Pageof 59